Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents-Reference-Cited by-同舟云学术

Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents

Published:2015-04 Issue:2 Volume:16 Page:72-80
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Rockstroh Juergen K.,Soriano Vicente,Plonski Frank,Bansal Meena,Fätkenheuer Gerd,Small Catherine B.,Asmuth David M.,Pialoux Gilles,Mukwaya Geoffrey,Jagannatha Shyla,Heera Jayvant,Pineda Juan A.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1179/1528433614Z.0000000011

Reference19 articles.

1. Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection

3. Viral Hepatitis in HIV Infection

4. Management of hepatitis C/HIV coinfection

5. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CC chemokines family in fibrosis and aging: From mechanisms to therapy;Ageing Research Reviews;2023-06

2. Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone;BMJ Open;2020-07

3. Clinical significance of chemokine receptor antagonists;Expert Opinion on Drug Metabolism & Toxicology;2020-01-02

4. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro;PLOS ONE;2019-10-29

5. Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1;Pediatric Infectious Disease Journal;2018-05